The clinical landscape for managing internal scarring has entered a transformative phase in 2026, with the global market projected to grow from $123.66 billion to over $180 billion by 2035. For decades, medical intervention was limited to slowing the rate of decline, but 2026 has ushered in a wave of regenerative medicine breakthroughs. Researchers are now leveraging mesenchymal stem cells and...
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt